International Clinical Trial: Efficacy and Safety of Minocycline-Vonoprazan Dual Therapy Versus Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Multicenter, Open-Label, Randomized, Non-Inferiority Study

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122517) titled 'Efficacy and Safety of Minocycline-Vonoprazan Dual Therapy Versus Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Multicenter, Open-Label, Randomized, Non-Inferiority Study' on April 14.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Nanchang University

Condition: Helicobacter pylori infection

Intervention: 14-day minocycline and vonoprazan dual therapy:14-day minocycline and vonoprazan dual therapy

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-04-15

Target Sample Size: 14-day minocyc...